It can enhance the survival and proliferation of cancer cells, and its presence in the TME is often associated with a poor prognosis in several cancers (74–77) Similarly, IL-13 has been implicated in tumor progression and metastasis (73, 78). This evidence concerns the gene IL13 and neoplasm.